Status:
COMPLETED
Postprandial Fatty Acids and FABP2 in Type 2 Diabetes Mellitus (DM)
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Conditions:
Dyslipidemia
Type 2 Diabetes Mellitus
Eligibility:
All Genders
40-75 years
Phase:
NA
Brief Summary
This study will be conducted in type 2 diabetic patient's to evaluate the if there is a different response of serum lipids after a standard meal (rich in saturated fatty acids) in patients who have th...
Detailed Description
Background: The presence of Ala54Thr polymorphism of intestinal fatty acid-binding protein 2 gene (FABP2) might influence the intestinal absorption of dietary fatty acids (FAs) and has been associated...
Eligibility Criteria
Inclusion
- Type 2 diabetes
- homozygote to FABP2 polymorphism:TT or AA
Exclusion
- age \>75 years
- glomerular filtration rate \<30ml min-1
- with unstable angina or possible infarct or stroke in the last year
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00634673
Start Date
June 1 2006
End Date
October 1 2007
Last Update
March 13 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90035-003